Pharma Industry News

France’s Osivax raises over €30m for universal flu and coronavirus vaccines

Company’s technology designed to train immune system to recognise internal virus proteins

Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]